Ozempic, Wegovy and Mounjaro are changing the conversation around obesity and weight management. For many people, GLP-1 receptor agonists can mean less hunger, fewer cravings and relief from the constant “food noise” that can make weight loss feel impossible.
But as these medicines become more mainstream, the conversation is becoming more complex. Weight loss is not automatically the same as better health - and when appetite drops, it can become harder to eat enough protein, fibre and essential micronutrients, while protecting muscle mass matters more than ever.
In this episode of Vision of Health, Dr Frankie Jackson-Spence is joined by nutrition therapist Ian Marber, author of The GLP-1 Handbook, to look beyond the headlines. They explore how GLP-1 medications such as Ozempic and Mounjaro work, who they may be suitable for, the nutritional considerations during treatment, and how to use them as part of a sustainable approach to long-term health.
With more than 25 years of clinical experience, including a practice on London’s Harley Street, Ian brings a practical and grounded perspective to one of the biggest conversations in modern health.
GLP-1 medications can be powerful tools, but they are not the whole picture. What you eat, how you move and how you maintain muscle all matter too.
The goal isn't simply to lose weight. It's to support your health and build something that lasts.
Learn More About Ian Marber: Ian Marber's website
Follow Ian on Instagram: @ianmarber_
Follow Dr Frankie Jackson-Spence: @drfrankiejs
And don’t forget to follow Vision of Health on Instagram too: @visionofhealthpod
If you learnt something from this episode, share it with someone who is trying to understand GLP-1 medications such as Ozempic and Mounjaro, how they work and whether they might be right for them.
","author_name":"Dr Frankie Jackson-Spence"}